BioInformant Worldwide, L.L.C.

41 Reports from BioInformant Worldwide, L.L.C.

• Strategic Development of Neural Stem and Progenitor Cell Products

  Mar 01, 2019 | USD 3,795

  ... brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny ... Read More

• Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends

  Feb 01, 2019 | USD 3,795

  ... acute lymphoblastic leukemia (ALL). Soon after, on October 18, 2017, FDA granted approval for Axicabtagene ciloleucel (Yescarta) for treating patients with relapsed/refractory diffuse large B-cell lymphoma (r/rDLBCL) and other rare large B-cell lymphomas. Other notable ... Read More

• Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2018-19

  Oct 15, 2018 | USD 3,795

  ... stem cells through the manipulation of gene expression, as well as other methods. Research and experimentation using mouse cells by Shinya Yamanaka’s lab at Kyoto University in Japan was the first instance in which there ... Read More

• Global Cord Blood Banking Industry Report 2018

  Apr 01, 2018 | USD 3,795

  ... has created both serious threats and novel opportunities for the industry. Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular ... Read More

• Mesenchymal Stem Cells - Advances & Applications (2018)

  Feb 01, 2018 | USD 3,795

  ... other cell types. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types ... Read More

• Strategic Development of Neural Stem & Progenitor Cell Products (2018)

  Jan 01, 2018 | USD 2,995

  ... the growing brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are ... Read More

• The Market for Stem Cell Exosomes

  Dec 01, 2017 | USD 2,795

  ... cells to patients. Although exosomes were discovered more than 30 years ago, it was not until recently that the scientific community began to give credit to exosomes for a range of promising traits. Ten years ... Read More

• Market Size Determination for the Cell Therapy CDMO Market

  Oct 01, 2017 | USD 297

  ... such as cell therapy contract and development manufacturing organizations (CDMOs). Benefits of partnering with a cell therapy CDMO include scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies. With more ... Read More

• Complete 2017-18 Global Cord Blood Banking Industry Report

  Oct 01, 2017 | USD 3,795

  ... opportunities for the industry. Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular therapies, and an increasing trend toward industry ... Read More

• The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, and Distribution

  Jul 01, 2017 | USD 2,495

  ... cell therapy products has introduced manufacturing complexity and regulatory concerns, as well as scale-up complexities that are not present within traditional pharmaceutical manufacturing. Furthermore, much of cell therapy manufacturing now involves patient-specific cell therapies, where ... Read More

• Defining the Future of the Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives

  Jul 01, 2017 | USD 1,795

  ... ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to differentiate into a wide variety of specialized cell types. In a developing embryo, stem cells can differentiate into all ... Read More

• Stem Cell Research Products - Opportunities, Tools, & Technologies

  Feb 01, 2016 | USD 3,795

  ... identify new product development opportunities before the competition. Use the “Survey of Stem Cell Scientists” to understand technical requirements, unmet needs, and purchasing preferences of stem cell researchers worldwide. This report explores unique market opportunities ... Read More

• Mesenchymal Stem Cells - Advances & Applications

  Nov 01, 2015 | USD 3,795

  ... Applications.” Published November 2015, it presents 250 pages of coverage for the rapidly-evolving mesenchymal stem cell (MSC) industry. Called the "most innovative market research firm in the world,” BioInformant tracks MSC industry metrics using continuously ... Read More

• Complete 2015-16 Global Cord Blood Banking Industry Report

  Aug 01, 2015 | USD 3,795

  ... is designed to increase your efficiency and effectiveness in: 1.Commercializing cord blood products, technologies, and therapies 2.Making intelligent investment decisions 3.Launching high-demand products 4.Selling effectively to your client base 5.Increasing revenue 6.Taking market share from ... Read More

• The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends.

  Jun 01, 2015 | USD 1,395

  ... the stem cell biobanking market. This global strategic report is produced for: Executives of Industrial-Scale Biobanks Management of Stem Cell Product Companies Management of Stem Cell Therapy Companies Biobanking Industry Investors It is designed to ... Read More

• Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report

  Apr 01, 2015 | USD 3,795

  ... affecting industry patent rights, announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific ... Read More

< prev 1 2 Next >